
Bangkok(VNA) - Human trials of a COVID-19 vaccine in Thailand are expected to beginwithin the next four months, according to the Department of Disease Control(DDC) of the country.
The announcement follows an initial cooperation agreement between the ThaiMinistry of Public Health and Chinese pharmaceutical companies in developing avaccine against the SARS-CoV-2.
Speaking at a meeting of the National Vaccine Committee, DDC chief SuwannachaiWattanayingcharoenchai said the National Vaccine Institute is preparing to signa Memorandum of Understanding (MoU) with Chinese partners to test a COVID-19vaccine in Thailand.
The trial is expected to involve more than 10,000 Thai citizens, he said,adding that DDC will consider possible candidates to work with.
According to Suwannachai, many laboratories in the country are ready to developa vaccine if their Chinese counterparts provide them with the technology.
Public Health Minister Anutin Charnvrirakul said he has ordered the NationalVaccine Institute to complete its vaccine development blueprint within threemonths so the country can go ahead with vaccine development projects.
The government has approved 45 billion THB for the fight against COVID-19,which included vaccine development, he noted.
Thailand on April 22 recorded 15 new cases of COVID-19, raising the total to2,826, including 49 deaths.
The number of infections reported by day in Thailand is on the decline, openingup the possibility that the government may ease restrictions across the countryin the coming time./.